echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Gastric Cancer: The most appropriate follow-up time after different stages of gastric cancer cure!

    Gastric Cancer: The most appropriate follow-up time after different stages of gastric cancer cure!

    • Last Update: 2021-01-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Surgeons often face an important question about how to plan follow-up after surgery to treat stomach cancer.
    , gastric cancer treatment surgery is usually followed up for 5 years.
    , however, it remains debatable how long the follow-up should last.
    this study provides a retrospective analysis of the clinical pathology database of patients undergoing a cured gastric excision at a Toronto hospital from 1975 to 2010, an analysis of follow-up and recurrence rates at various stages of surgery, and a follow-up endpoint at a recurrence rate of less than 1% after surgery.
    follow-up rate over time included 5,235 eligible patients.
    follow-up rate over the past five years was 90.3 per cent.
    the follow-up time, the follow-up rate decreased significantly: 52.7 per cent in 10 years, 38.3 per cent in 15 years and 10.3 per cent in 20 years.
    850 patients (16.2%) were confirmed to have relapsed, of which 50 were relapsed after five years.
    suitable follow-up endpoints for patients with different stages of postoperative survival are: IA 2 years, IB 4 years, IIA 6 years, IIB 9 years, IIIA 7 years, IV (cure) 8 years.
    there is also a risk of recurrence in patients with stage IIIB and stage IIIC stomach cancer.
    , the appropriate follow-up monitoring time for different stages of stomach cancer after removal may be different.
    Although the follow-up time for stage I gastric cancer can be reduced to less than 5 years, there is still a risk of recurrence 5 years after surgery for advanced gastric cancer (e.g. stage III or stage IV disease), so prolonged follow-up is required.
    findings may help surgeons develop postoperative follow-up plans for patients with stomach cancer.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.